Literature DB >> 26353792

The Deleted in Liver Cancer 1 (Dlc1) tumor suppressor is haploinsufficient for mammary gland development and epithelial cell polarity.

Pratima Basak1,2,3,4, Rachelle Dillon5, Heather Leslie6, Afshin Raouf7,8,9, Michael R A Mowat10,11.   

Abstract

BACKGROUND: Deleted in Liver Cancer 1 (Dlc1) is a tumor suppressor gene, which maps to human chromosome 8p21-22 and is found frequently deleted in many cancers including breast cancer. The promoter of the remaining allele is often found methylated. The Dlc1 gene encodes a RhoGAP protein that regulates cell proliferation, migration and inhibits cell growth and invasion when restored in Dlc1 deficient tumor cell lines. This study focuses on determining the role of Dlc1 in normal mammary gland development and epithelial cell polarity in a Dlc1 gene trapped (gt) mouse.
METHODS: Mammary gland whole mount preparations from 10-week virgin heterozygous Dlc1(gt/+) gene-trapped mice were compared with age-matched wild type (WT) controls. Hematoxylin-Eosin (H&E) and Masson's Trichrome staining of histological sections were carried out. Mammary glands from Dlc1(gt/+) mice and WT controls were enzymatically digested with collagenase and dispase and then cultured overnight to deplete hematopoietic and endothelial cells. The single cell suspensions were then cultured in Matrigel for 12 days. To knockdown Dlc1 expression, primary WT mammary epithelial cells were infected with short hairpin (sh) RNA expressing lentivirus or with a scrambled shRNA control.
RESULTS: Dlc1(gt/+) mice showed anomalies in the mammary gland that included increased ductal branching and deformities in terminal end buds and branch points. Compared to the WT controls, Masson's Trichrome staining showed a thickened stromal layer with increased collagen deposition in mammary glands from Dlc1(gt/+) mice. Dlc1(gt/+) primary mammary epithelial cells formed increased solid acinar spheres in contrast with WT and scrambled shRNA control cells, which mostly formed hollow acinar structures when plated in 3D Matrigel cultures. These solid acinar structures were similar to the acinar structures formed when Dlc1 gene expression was knocked down in WT mammary cells by shRNA lentiviral transduction. The solid acinar structures were not due to a defect in apoptosis as determined by a lack of detectible cleaved caspase 3 antibody staining. Primary mammary cells from Dlc1(gt/+) mice showed increased RhoA activity compared with WT cells.
CONCLUSIONS: The results illustrate that decreased Dlc1 expression can disrupt the normal cell polarization and mammary ductal branching. Altogether this study suggests that Dlc1 plays a role in maintaining normal mammary epithelial cell polarity and that Dlc1 is haploinsufficient.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26353792      PMCID: PMC4565020          DOI: 10.1186/s12885-015-1642-x

Source DB:  PubMed          Journal:  BMC Cancer        ISSN: 1471-2407            Impact factor:   4.430


  51 in total

1.  A PLCdelta1-binding protein, p122/RhoGAP, is localized in caveolin-enriched membrane domains and regulates caveolin internalization.

Authors:  Masaki Yamaga; Masayuki Sekimata; Makoto Fujii; Katsuhisa Kawai; Hideaki Kamata; Hajime Hirata; Yoshimi Homma; Hitoshi Yagisawa
Journal:  Genes Cells       Date:  2004-01       Impact factor: 1.891

Review 2.  Polarity in mammalian epithelial morphogenesis.

Authors:  Julie Roignot; Xiao Peng; Keith Mostov
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-02-01       Impact factor: 10.005

3.  Integrated analysis of copy number and loss of heterozygosity in primary breast carcinomas using high-density SNP array.

Authors:  Ho Ching Ching; Rakesh Naidu; Mun Kein Seong; Yip Cheng Har; Nur Aishah Mohd Taib
Journal:  Int J Oncol       Date:  2011-06-15       Impact factor: 5.650

4.  The RhoGAP protein DLC-1 functions as a metastasis suppressor in breast cancer cells.

Authors:  Steve Goodison; Jing Yuan; Derek Sloan; Ryung Kim; Cheng Li; Nicholas C Popescu; Virginia Urquidi
Journal:  Cancer Res       Date:  2005-07-15       Impact factor: 12.701

5.  Functional interaction of tumor suppressor DLC1 and caveolin-1 in cancer cells.

Authors:  Xiaoli Du; Xiaolan Qian; Alex Papageorge; Aaron J Schetter; William C Vass; Xi Liu; Richard Braverman; Ana I Robles; Douglas R Lowy
Journal:  Cancer Res       Date:  2012-06-12       Impact factor: 12.701

6.  The RhoGEF Net1 is required for normal mammary gland development.

Authors:  Yan Zuo; Rebecca Berdeaux; Jeffrey A Frost
Journal:  Mol Endocrinol       Date:  2014-12

7.  Toward a genetics of cancer resistance.

Authors:  George Klein
Journal:  Proc Natl Acad Sci U S A       Date:  2009-01-07       Impact factor: 11.205

8.  Oncogenic inhibition by a deleted in liver cancer gene requires cooperation between tensin binding and Rho-specific GTPase-activating protein activities.

Authors:  Xiaolan Qian; Guorong Li; Holly K Asmussen; Laura Asnaghi; William C Vass; Richard Braverman; Kenneth M Yamada; Nicholas C Popescu; Alex G Papageorge; Douglas R Lowy
Journal:  Proc Natl Acad Sci U S A       Date:  2007-05-15       Impact factor: 11.205

9.  p190-B RhoGAP regulates mammary ductal morphogenesis.

Authors:  Geetika Chakravarty; Darryl Hadsell; William Buitrago; Jeffrey Settleman; Jeffrey M Rosen
Journal:  Mol Endocrinol       Date:  2003-03-13

Review 10.  DLC-1:a Rho GTPase-activating protein and tumour suppressor.

Authors:  Marian E Durkin; Bao-Zhu Yuan; Xiaoling Zhou; Drazen B Zimonjic; Douglas R Lowy; Snorri S Thorgeirsson; Nicholas C Popescu
Journal:  J Cell Mol Med       Date:  2007 Sep-Oct       Impact factor: 5.310

View more
  7 in total

1.  Upregulation of DLC-1 inhibits pancreatic cancer progression: Studies with clinical samples and a pancreatic cancer model.

Authors:  Bo Chen; Mingzheng Xu; Ming Xu
Journal:  Oncol Lett       Date:  2019-09-16       Impact factor: 2.967

2.  Estrogen receptor signaling is reprogrammed during breast tumorigenesis.

Authors:  David Chi; Hari Singhal; Lewyn Li; Tengfei Xiao; Weihan Liu; Matthew Pun; Rinath Jeselsohn; Housheng He; Elgene Lim; Raga Vadhi; Prakash Rao; Henry Long; Judy Garber; Myles Brown
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-20       Impact factor: 11.205

Review 3.  Minireview: Mouse Models of Rho GTPase Function in Mammary Gland Development, Tumorigenesis, and Metastasis.

Authors:  Yan Zuo; Wonkyung Oh; Arzu Ulu; Jeffrey A Frost
Journal:  Mol Endocrinol       Date:  2015-12-17

4.  Functional validation of tensin2 SH2-PTB domain by CRISPR/Cas9-mediated genome editing.

Authors:  Kiyoma Marusugi; Kenta Nakano; Hayato Sasaki; Junpei Kimura; Rieko Yanobu-Takanashi; Tadashi Okamura; Nobuya Sasaki
Journal:  J Vet Med Sci       Date:  2016-05-30       Impact factor: 1.267

5.  PLEKHG5 regulates autophagy, survival and MGMT expression in U251-MG glioblastoma cells.

Authors:  Kaya Elisa Witte; Carsten Slotta; Melanie Lütkemeyer; Angelika Kitke; Roland Coras; Matthias Simon; Christian Kaltschmidt; Barbara Kaltschmidt
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

6.  Functional antagonism between CagA and DLC1 in gastric cancer.

Authors:  Isabel Hinsenkamp; Jan P Köhler; Christoph Flächsenhaar; Ivana Hitkova; Sabine Eberhart Meessen; Timo Gaiser; Thomas Wieland; Christel Weiss; Christoph Röcken; Michael Mowat; Michael Quante; Karin Taxauer; Raquel Mejias-Luque; Markus Gerhard; Roger Vogelmann; Nadja Meindl-Beinker; Matthias Ebert; Elke Burgermeister
Journal:  Cell Death Discov       Date:  2022-08-13

7.  High expression of DLC family proteins predicts better prognosis and inhibits tumor progression in NSCLC.

Authors:  Li Sun; Jing Sun; Jun-Ding Song
Journal:  Mol Med Rep       Date:  2019-04-10       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.